Immuron (IMRN) Shares Outstanding (Weighted Average) (2016 - 2025)

Immuron (IMRN) recorded quarterly Shares Outstanding (Weighted Average) of $888.7 million in Q3 2025, up 500.9% quarter-over-quarter from $147.9 million in Q2 2025, and little changed on a YoY basis from $885.0 million in Q3 2024.

Immuron (IMRN) Shares Outstanding (Weighted Average) (2016 - 2025) Analysis & Trends

Immuron's Shares Outstanding (Weighted Average) history runs 10 years deep, the most recent figure standing at $888.7 million for Q3 2025.

  • In Q3 2025, Shares Outstanding (Weighted Average) changed 0.42% year-over-year to $888.7 million; the TTM figure through Sep 2025 stood at $888.7 million (changed 0.42% YoY), while the FY2025 annual figure was $888.7 million, changed 0.42% from the prior year.
  • Shares Outstanding (Weighted Average) was $888.7 million for Q3 2025 at Immuron, up from $147.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $888.7 million in Q3 2025 to a low of $57.9 million in Q4 2024.
  • Historically, Shares Outstanding (Weighted Average) has averaged $294.6 million across 5 years, with a median of $106.3 million in 2025.
  • The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Weighted Average) soared 1337.97% in 2023, then plunged 89.94% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $64.7 million in 2021, then slipped by 10.17% to $58.1 million in 2022, then surged by 890.82% to $575.7 million in 2023, then slumped by 89.94% to $57.9 million in 2024, then surged by 1434.09% to $888.7 million in 2025.
  • The last three Shares Outstanding (Weighted Average) figures came in at $888.7 million (Q3 2025), $147.9 million (Q2 2025), and $57.9 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 185,491.37 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 100.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 417.01 Bn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 254.10 Mn
9 Abivax 91.96 Bn 91.96 Bn - 928.40 Mn
10 Immuron 921.61 Mn 921.58 Mn - 888.73 Mn

Historic Data

Download Data
DateValue
Sep 2, 2025 888.73 Mn
Jun 30, 2025 147.90 Mn
Dec 31, 2024 57.93 Mn
Sep 9, 2024 885.04 Mn
Jun 30, 2024 150.17 Mn
Dec 31, 2023 575.71 Mn
Sep 28, 2023 57.97 Mn
Aug 30, 2023 884.36 Mn
Jun 30, 2023 59.11 Mn
Dec 31, 2022 58.10 Mn
Aug 31, 2022 61.50 Mn
Jun 30, 2022 63.34 Mn
Dec 31, 2021 64.68 Mn
Jun 30, 2021 170.23 Mn
Jun 30, 2020 115.61 Mn
Dec 31, 2019 624.27 Mn
Jun 30, 2019 101.39 Mn
Dec 31, 2018 1,200.00
Aug 30, 2018 58.37 Mn
Jun 30, 2018 44.19 Mn